Status: Recruiting
Evaluation of GM101 Injection in Patients With Parkinson's Disease
The objective of this study is to assess the safety of GM101 in participants with Parkinson's disease (PD)
Participants needed: 10
Trial details
Phase: Early Phase 1Age: 40-70Biological sex: AllType: InterventionalSponsor: Genemagic Biosciences Co., LtdUpdated: Aug 3, 2025Locations: 1
Eligibility criteria
Clinically diagnosed patients with primary Parkinson's Disease [in accordance wi... [+16]
Patients with atypical parkinsonian syndromes (Parkinson-plus syndromes, seconda... [+8]